MHC-peptide tetramers for the analysis of antigen-specific T cells

Expert Review of Vaccines

Volumn 9, Issue 7, 2010, Pages 765-774

  Sims, Stuart ^a   Willberg, Christian ^a   Klenerman, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

adoptive T cell transfer; CD4+ T cells; CD8+ T cells; intracellular cytokine staining; MHC class I; MHC class II; phenotyping; tetramer guided epitope mapping; tetramers

Indexed keywords

BETA 2 MICROGLOBULIN; CD1 ANTIGEN; CD45 ANTIGEN; CYTOKINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR; TETRAMER;

ADOPTIVE TRANSFER; ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL PROLIFERATION; CELL SELECTION; CELLULAR IMMUNITY; CYTOKINE RELEASE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HOST RESISTANCE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

ANIMALS; EPITOPE MAPPING; HISTOCOMPATIBILITY ANTIGENS; HUMANS; PEPTIDES; PROTEIN MULTIMERIZATION; T-LYMPHOCYTES;

EID: 77954661768     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.66     Document Type: Review

References (74)

1. Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274(5284), 94-96 (1996).
2. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375(6527), 148-151 (1995).
3. Laugel B, Boulter JM, Lissin N et al. Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition. J. Biol. Chem. 280(3), 1882-1892 (2005).
4. Whelan JA, Dunbar PR, Price DA et al. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163(8), 4342-4348 (1999).
5. 4+ T cells with class II MHC oligomers. J. Immunol. Methods 268(1), 51-69 (2002).
6. 4+ T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramer. J. Virol. 74(18), 8751-8756 (2000).
7. 4+ T cells using recombinant artificial APC: following the antiovalbumin immune response. J. Immunol. 170(1), 123-131 (2003).
8. Stratmann T, Martin-Orozco N, Mallet-Designe V et al. Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J. Clin. Invest. 112(6), 902-914 (2003).
9. Liu G, Wang Q, Tong T et al. Construction and functional test of a chicken MHC-I (BF2*15)/peptide tetramer. Vet. Immunol. Immunopathol. 122(1-2), 1-7 (2008).
10. 8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes. Virology 339(1), 110-126 (2005).
11. Oleksiewicz MB, Kristensen B, Ladekjaer-Mikkelsen AS, Nielsen J. Development of a rapid in vitro protein refolding assay which discriminates between peptide-bound and peptide-free forms of recombinant porcine major histocompatibility class I complex (SLA-I). Vet. Immunol. Immunopathol. 86(1-2), 55-77 (2002).
12. 8+ T cell responses in macaques infected with simian immunodeficiency virus. Virology 272 (2), 347-356 (2000).
13. Dunbar PR, Ogg GS, Chen J, Rust N, van der Bruggen P, Cerundolo V. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 8(7), 413-416 (1998).
14. 4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection. PLoS One 5(3), e9787 (2010).
15. Niemiec PK, Read LR, Sharif S. Synthesis of chicken major histocompatibility complex class II oligomers using a baculovirus expression system. Protein Expr. Purif. 46(2), 390-400 (2006).
16. Garboczi DN, Hung DT, Wiley DC. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl Acad. Sci. USA 89(8), 3429-3433 (1992).
17. Leisner C, Loeth N, Lamberth K et al. One-pot, mix-and-read peptide-MHC tetramers. PLoS One 3(2), e1678 (2008).
18. 8+ T cells. J. Immunol. Methods 310(1-2), 136-148 (2006).
19. Christmas SE, Halliday D, Lawton N et al. Cytomegalovirus-specific CD8 + T cells do not develop in all renal transplant patients at risk of virus infection. Transplant Immunol. 22(1-2), 99-104 (2009).
20. Bakker AH, Hoppes R, Linnemann C et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc. Natl Acad. Sci. USA 105(10), 3825-3830 (2008).
21. Soen Y, Chen DS, Kraft DL, Davis MM, Brown PO. Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol. 1(3), E65 (2003).
22. Crawford F, Kozono H, White J, Marrack P, Kappler J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8(6), 675-682 (1998).
23. Yang J, Jaramillo A, Shi R, Kwok WW, Mohanakumar T. In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers. Hum. Immunol. 65(7), 692-699 (2004).
24. Kozono H, White J, Clements J, Marrack P, Kappler J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369(6476), 151-154 (1994).
25. 4+ T cells in resistant mice upon infection with Leishmania major. Immunity 13(6), 771-782 (2000).
26. 4+ T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104(12), R63-R67 (1999).
27. Moro M, Cecconi V, Martinoli C et al. Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides. BMC Immunol. 6, 24 (2005).
28. Lebowitz MS, O'Herrin SM, Hamad AR et al. Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses. Cell. Immunol. 192(2), 175-184 (1999).
29. Day CL, Seth NP, Lucas M et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 112(6), 831-842 (2003).
30. Porcelli SA. The CD1 family: a third lineage of antigen-presenting molecules. Adv. Immunol. 59, 1-98 (1995).
31. Benlagha K, Bendelac A. CD1d-restricted mouse V a 14 and human V a 24 T cells: lymphocytes of innate immunity. Semin. Immunol. 12(6), 537-542 (2000).
32. Matsuda JL, Naidenko OV, Gapin L et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192(5), 741-754 (2000).
33. Guillaume P, Dojcinovic D, Luescher IF. Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research. Cancer Immun. 9, 7 (2009).
34. Komatsu H, Sierro S, V Cuero A, Klenerman P. Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin. Exp. Immunol. 134(1), 9-12 (2003).
35. 4+ T lymphocyte turnover and activation increase upon viral rebound. J. Clin. Invest. 115(2), 443-450 (2005).
36. Day CL, Kiepiela P, Leslie AJ et al. Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection. J. Virol. 81(1), 434-438 (2007).
37. 8+ T cells. Eur. J. Immunol. 34(6), 1570-1577 (2004).
38. Lucas M, Day CL, Wyer JR et al. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J. Virol. 78(13), 7284-7287 (2004).
39. 4+ T cell epitopes from complex antigens. J. Immunol. 166(11), 6665-6670 (2001).
40. Reijonen H, Kwok WW. Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods 29(3), 282-288 (2003).
41. Kwok WW, Gebe JA, Liu A et al. Rapid epitope identification from complex class-II-restricted T-cell antigens. Trends Immunol. 22(11), 583-588 (2001).
42. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243(1-2), 147-154 (2000).
43. 8+ T cells differently expressing three cytolytic effector molecules. J. Immunol. 177(7), 4330-4340 (2006).
44. 8+ T lymphocyte activation in response to therapeutic manipulation of virus load. Eur. J. Immunol. 31(4), 1115-1121 (2001).
45. 8+ T cell populations after murine cytomegalovirus infection. Eur. J. Immunol. 35(4), 1113-1123 (2005).
46. 8+ T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192(1), 63-75 (2000).
47. Holmberg K, Mariathasan S, Ohteki T, Ohashi PS, Gascoigne NR. TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR. J. Immunol. 171(5), 2427-2434 (2003).
48. Delon J, Gregoire C, Malissen B et al. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity 9(4), 467-473 (1998).
49. 8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281(1-2), 65-78 (2003).
50. Streeck H, Cohen KW, Jolin JS et al. Rapid ex vivo isolation and long-term culture of human Th17 cells. J. Immunol. Methods 333(1-2), 115-125 (2008).
51. 4+ T-cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J. Immunol. 180(7), 4514-4522 (2008).
52. Assenmacher M, Lohning M, Radbruch A. Detection and isolation of cytokine secreting cells using the cytometric cytokine secretion assay. Curr. Protoc. Immunol. Chapter 6, Unit 6 27 (2002).
53. Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29(4), 650-659 (2008).
54. 8+ T cells over time. J. Immunol. 170(4), 2022-2029 (2003).
55. Shin H, Blackburn SD, Intlekofer AM et al. A role for the transcriptional repressor Blimp-1 in CD8 + T cell exhaustion during chronic viral infection. Immunity 31(2), 309-320 (2009).
56. 4+ CD25Hi regulatory T cells. Int. Immunol. 21(9), 1065-1077 (2009).
57. Jain N, Nguyen H, Chambers C, Kang J. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc. Natl Acad. Sci. USA 107(4), 1524-1528 (2010).
58. Skinner PJ, Daniels MA, Schmidt CS, Jameson SC, Haase AT. Cutting edge: in situ tetramer staining of antigen-specific T cells in tissues. J. Immunol. 165(2), 613-617 (2000).
59. Li Q, Skinner PJ, Ha SJ et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323(5922), 1726-1729 (2009).
60. De Vries IJ, Bernsen MR, van Geloof WL et al. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. Cancer Immunol. Immunother. 56(10), 1667-1676 (2007).
61. Casalegno-Garduno R, Schmitt A, Yao J et al. Multimer technologies for detection and adoptive transfer of antigen-specific T cells. Cancer Immunol. Immunother. 59(2), 195-202 (2010).
62. 8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers. Tumour Biol. 28(2), 70-76 (2007).
63. Cobbold M, Khan N, Pourgheysari B et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202(3), 379-386 (2005).
64. Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, Ahmed R. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205(3), 625-640 (2008).
65. 8+ T cell exhaustion during chronic viral infection. Immunity 27(4), 670-684 (2007).
66. Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111(6), 837-851 (2002).
67. 8+ T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers. J. Immunol. Methods 338(1-2), 31-39 (2008).
68. Wooldridge L, Lissina A, Vernazza J et al. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur. J. Immunol. 37(5), 1323-1333 (2007).
69. Newell EW, Klein LO, Yu W, Davis MM. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat. Methods 6(7), 497-499 (2009).
70. Janetzki S, Britten CM, Kalos M et al. 'MIATA' - minimal information about T cell assays. Immunity 31(4), 527-528 (2009).
71. MIATA Reporting Framework http://www.miataproject.org
72. Cancer Immunity http://www.cancerimmunity.org
73. Stanford School of Medicine. HIMC - Human Immune Monitoring Center http://iti.stanford.edu/research/human-/immune-monitoring.html
74. Oxford Biomedical Research Centre: Translation Immunology Laboratory http://oxfordbrc.org/immunity/research-/areas/172